These experiments have shown that myricetin is a powerful inhibitor for intestinal GLUT2, leading to therapeutic potential of myricetin for treatment of hyperglycemia through suppression of intestinal glucose absorption. This evidence concerns the gene SLC2A2 and Hyperglycemia.